Maxim analyst Allen Klee downgraded Marpai to Hold from Buy. The company’s Q3 results exceeded estimates, but the risk of dilution from its upcoming capital needs and the recent management changes balances its attractive technology and market opportunity, the analyst tells investors in a research note. The firm further cites the new management team having suspended guidance, with a call scheduled on 11/29 to discuss the strategic vision and initiatives in place.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on MRAI:
- Marpai downgraded to Hold from Buy at Maxim
- MARPAI, INC. REPORTS THIRD QUARTER 2023 RESULTS
- Marpai appoints Damien Lamendola as CEO, Steve Johnson as CFO
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue